☆ 4.3 Article

Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl Use

JOURNAL OF ADDICTION MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Recurrent Takotsubo Cardiomyopathy Associated with Opioid Withdrawal During Buprenorphine Induction

Nazila Jamshidi et al.

Summary: This case report describes a 65-year-old female with iatrogenic opioid use disorder who developed Takotsubo cardiomyopathy on multiple occasions following buprenorphine induction for chronic lower back pain. The report highlights the potential consequences of precipitated withdrawal with buprenorphine in an opioid transfer, and suggests that clonidine may play a role in preventing cardiotoxicity in such cases.

CARDIOVASCULAR TOXICOLOGY (2021)

Add to Collection

Article Clinical Neurology

Ketamine's rapid antisuicidal effects are not attenuated by Buprenorphine

Avinash Hosanagar et al.

Summary: Ketamine's rapid antisuicidal effects have garnered clinical interest, with recent research suggesting that its effects may not be solely through opioid pathways. This case study demonstrates that Buprenorphine does not block Ketamine's antisuicidal effects, and that Ketamine treatment can be safely administered to patients on Buprenorphine. Additionally, non-opioid mechanisms may be involved in Ketamine's antidepressant effects and response to suicidal ideations in patients on opioid partial agonists.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Add to Collection

Review Pharmacology & Pharmacy

The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder

Joao P. De Aquino et al.

Summary: Expanding access to buprenorphine for opioid-use disorder treatment has increased healthcare system capacity but starting this medication poses significant challenges. Microinduction, a novel approach utilizing buprenorphine's pharmacological profile, shows promise in improving clinical outcomes for patients with OUD by potentially circumventing the need for prolonged opioid tapers and reducing the risk of precipitated withdrawal. Despite diverse evidence, including variable buprenorphine formulations and dosages, preliminary data support the feasibility of microinduction and offer new insights for future research in pharmacotherapy development.

CLINICAL DRUG INVESTIGATION (2021)

Add to Collection

Editorial Material Psychiatry

The epidemic of fentanyl misuse and overdoses: challenges and strategies

Nora D. Volkow

WORLD PSYCHIATRY (2021)

Add to Collection

Article Medicine, General & Internal

High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder

Andrew A. Herring et al.

Summary: The study showed that high-dose buprenorphine induction in an urban emergency department was found to be safe and well tolerated for patients with untreated OUD. Further investigations in multiple sites are recommended to confirm these findings.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Substance Abuse

Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone

Denis Antoine et al.

Summary: This case series described buprenorphine/naloxone inductions of four individuals who tested positive for fentanyl, and indicated that a revised induction strategy could help prevent precipitated withdrawal in individuals exposed to illicit fentanyl.

AMERICAN JOURNAL ON ADDICTIONS (2021)

Add to Collection

Article Substance Abuse

Protracted renal clearance of fentanyl in persons with opioid use disorder

Andrew S. Huhn et al.

DRUG AND ALCOHOL DEPENDENCE (2020)

Add to Collection

Article Anesthesiology

Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals

Andrew S. Huhn et al.

ANESTHESIOLOGY (2019)

Add to Collection

Editorial Material Emergency Medicine

Managing Opioid Withdrawal in the Emergency Department With Buprenorphine

Andrew A. Herring et al.

ANNALS OF EMERGENCY MEDICINE (2019)

Add to Collection

Editorial Material Psychiatry

A possible role for ketamine in suicide prevention in emergency and mainstream psychiatry

T. S. Sathyanarayana Rao et al.

INDIAN JOURNAL OF PSYCHIATRY (2017)

Add to Collection

Article Emergency Medicine

The first 500: initial experience with widespread use of low-dose ketamine for acute pain management in the ED

Terence L. Ahern et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2015)

Add to Collection

Review Substance Abuse

Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy

Mark K. Greenwald et al.

DRUG AND ALCOHOL DEPENDENCE (2014)

Add to Collection

Letter Emergency Medicine

Emerging applications of low-dose ketamine for pain management in the ED

Andrew A. Herring et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2013)

Add to Collection

Letter Anesthesiology

The Use of a Subanesthetic Infusion of Intravenous Ketamine to Allow Withdrawal of Medically Prescribed Opioids in People with Chronic Pain, Opioid Tolerance and Hyperalgesia: Outcome at 6 Months

John Quinlan

PAIN MEDICINE (2012)

Add to Collection

Article Biochemistry & Molecular Biology

Potentiation of μ-opioid receptor-mediated signaling by ketamine

Achla Gupta et al.

JOURNAL OF NEUROCHEMISTRY (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.